Life Sciences Greenhouse Investments
Venture capitalPennsylvania · Pre-Seed–Series B · 11 people tracked
Investment thesis
The fund supports early-stage life sciences companies in Pennsylvania focused on drug discovery, diagnostics, medical devices, product commercialization, and IT-driven healthcare solutions. Beyond capital deployment, the firm provides operational support through connections to scientific and business experts to help portfolio companies navigate the unique challenges of developing healthcare innovations.
Source: firm website, verified Jul 21, 2026.
Team · 11 people
from the firm's website
Michele Washko brings over 25 years of experience in healthcare commercialization, finance, and innovation to her role leading LSG Investments.
Greg Jackson holds responsibility for identifying new investment opportunities, conducting due diligence, and mentoring and monitoring the performance of portfolio companies.
What they invest in
from 14 of 22 portfolio companiesHealthtech ×11Medical Devices ×11AI & Machine Learning ×5Biotech ×5Deep Tech ×4Digital Health ×3Advanced Manufacturing ×1Data & Infrastructure ×1
HQs:United States×4Chile×1
Investments · 22 tracked
founders shown can be your intro pathUnable to determine company information; page contains only placeholder Lorem ipsum text.
AI & Machine LearningDigital HealthHealthtech
Betsy Castillo(Head of Clinical Data Abstraction)
Avisi develops VisiPlate, a nanotechnology-enabled implant designed to lower intraocular pressure in patients with open-angle glaucoma. The company is conducting a pivotal clinical trial (SAPPHIRE) to evaluate the device as a minimally-invasive treatment option.
Deep TechHealthtechMedical Devices
BioLattice develops engineered cornea tissue as an alternative to donor cornea for patients with corneal blindness and those waiting for transplants. The company focuses on tissue engineering to address the shortage of donor cornea supply in the global ophthalmology market.
BiotechHealthtechMedical DevicesPhiladelphia, US
ChromaTan develops biomanufacturing solutions that accelerate product development. The company focuses on manufacturing and biotech applications.
Advanced ManufacturingBiotechDeep Tech
Forma Medical develops OptimalMTP, a minimally invasive surgical system for first metatarsophalangeal joint arthrodesis that combines plate-and-screw biomechanics with smaller incision techniques for foot surgeons.
HealthtechMedical Devices
Ilico Genetics develops a blood-based molecular test for the early detection of gastric cancer using methylated DNA markers, designed to identify disease years before traditional methods. The company serves gastroenterologists and patients in the oncology diagnostics space, with a platform technology applicable to precision medicine and disease prevention.
BiotechHealthtechMedical DevicesSantiago, CL
Alejandro Corvalán(MD)inFernando Alarcon(MBA)inMaria J. Maturana(MSc)in
Immunomic Therapeutics develops nucleic acid immunotherapy platforms, particularly self-amplifying RNA and plasmid DNA vaccines, for cancer treatment, allergies, and animal health applications. The company's UNITE® platform leverages lysosomal targeting technology to generate immune responses against CMV, HPV, and other tumor-associated antigens across multiple cancer types and allergic conditions.
BiotechMedical Devices
INDIGO Biosciences is a life sciences company led by professionals with expertise in life sciences, business management, and operations.
AI & Machine LearningBiotechDeep TechMedical DevicesState College, US
Dr. Jack Vanden HeuvelDr. Blake Peterson
Innsightech develops technology for disease diagnosis and management that translates laboratory innovations into clinical applications. The company serves ophthalmologists and clinical practitioners.
Digital HealthHealthtechMedical Devices
Lumithera develops Valeda PBM, an FDA-authorized photobiomodulation light delivery system for treating dry age-related macular degeneration (AMD) to improve and maintain vision. The non-invasive treatment targets retinal cellular health by using specific light wavelengths to enhance mitochondrial energy production.
HealthtechMedical Devices
Micro Interventional Devices designs and manufactures medical devices for transcatheter cardiac repair procedures, enabling minimally invasive alternatives to open-heart surgery. The company initially focuses on transcatheter mitral and tricuspid valve repair solutions.
Deep TechHealthtechMedical DevicesNewtown, US
Michael Whitman(Founder, President, & CEO)
OK2StandUP develops smart activity monitoring systems with AI-based alerts for healthcare organizations to prevent falls and support caregiver awareness in patient care settings. The solution serves hospitals, rehabilitation facilities, memory care facilities, and other care environments for older adults.
AI & Machine LearningHealthtechMedical DevicesPittsburgh, US
Eunice Yang, PhD(Founder and CEO)
Veradigm provides software solutions and data platform services for payers, providers, and life science companies in healthcare, combining clinical insights with research capabilities and provider network data.
AI & Machine LearningData & InfrastructureDigital HealthEnterprise SoftwareHealthtech
sovaSage develops technology that optimizes the CPAP mask-fitting process for sleep apnea patients. The company works with sleep labs and medical equipment distributors to improve patient outcomes in the sleep apnea treatment sector.
AI & Machine LearningHealthtechMedical Devices
Frequently asked questions
- What stage does Life Sciences Greenhouse Investments invest at?
- Life Sciences Greenhouse Investments invests at the Pre-Seed, Seed, Series A, Series B stages.
- What is Life Sciences Greenhouse Investments's typical check size?
- Life Sciences Greenhouse Investments typically writes checks of $250K – $500K.
- What sectors does Life Sciences Greenhouse Investments focus on?
- Life Sciences Greenhouse Investments focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Life Sciences Greenhouse Investments located?
- Life Sciences Greenhouse Investments is headquartered in Pennsylvania, US.
- Does Life Sciences Greenhouse Investments lead rounds?
- Life Sciences Greenhouse Investments typically participates in rounds rather than leading them.
Images
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
A venture capital firm focused on precision health innovations that leverage artificial intelligence and technology to address significant unmet medical needs. MEC combines investment professionals with a proprietary national medical network platform to deploy capital across company creation, seed, Series A, and Series B stages.